Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Renal Cell Cancer, An Issue of Hematology/Oncology Clinics of North America

Renal Cell Cancer, An Issue of Hematology/Oncology Clinics of North America

9780323938990
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
483.79 zł
411.22 zł Save 72.57 zł Tax included
Lowest price within 30 days before promotion: 411.22 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Hematology/Oncology Clinics, guest editors Drs. Bradley A. McGregor and Toni K. Choueiri bring their considerable expertise to the topic of Renal Cell Cancer. Top experts in the field cover key topics such as VHL and HIF at the center of renal cell cancer biology; immunobiology and metabolic pathways of renal cell cancer; hereditary renal cell cancer syndromes; the role of the pathologist in renal cell cancer; novel imaging in renal cell cancer; and more.
Product Details
Elsevier
98512
9780323938990
9780323938990

Data sheet

Publication date
2023
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
152 x 229
Weight (g)
540
  • von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology
    Immunobiology and Metabolic Pathways of Renal Cell Carcinoma
    Hereditary Renal Cell Carcinoma Syndromes
    The Role of the Pathologist in Renal Cell Carcinoma Management
    Insights into Renal Cell Carcinoma with Novel Imaging Approaches
    Surgical Management of Localized Disease and Small Renal Masses
    Role of Surgery in Metastatic Renal Cell Carcinoma
    Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
    Role of Radiation in Treatment of Renal Cell Carcinoma
    Prognostic Models in Metastatic Renal Cell Carcinoma
    Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma
    Managing First-Line Metastatic Renal Cell Carcinoma: Favorable-Risk Disease
    First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma
    Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy
    Renal Cell Carcinoma of Variant Histology: Biology and Therapies
    Toxicity Management of Systemic Kidney Cancer Therapies
    Management of Brain Metastases in Metastatic Renal Cell Carcinoma
    Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR Inhibition
    Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes
Comments (0)
Viewed products